Patients and specialists present the first consensus for the comprehensive approach to chronic urticaria in Spain

Patients and experts agree on the first consensus in Spain for comprehensive, coordinated, and person-centered care for chronic urticaria.

3 minutes

Add DEMÓCRATA to Google

Published

3 minutes

The pharmaceutical company Novartis has promoted in Spain the first consensus document that proposes an integrated approach to chronic urticaria. This work has been developed by representatives of patients and by professionals from Dermatology, Allergology, Primary Care, and Hospital Pharmacy.

Specifically, the publication "Commitment to comprehensive care for chronic urticaria in Spain", developed independently by an advisory committee, has made it possible to define five key priorities to optimize care for this disease. The text is presented as a roadmap to move toward a more coordinated, patient-needs-centered care model.

Endorsed by the Spanish Academy of Dermatology and Venereology (AEDV) and by the Spanish societies of Allergology and Clinical Immunology (SEAIC) and of Primary Care Physicians (SEMERGEN), the consensus recalls that chronic urticaria is an inflammatory skin condition characterized by the repeated appearance of wheals—hives—, angioedema, or both for more than six weeks, generally accompanied by intense itching.

It is currently estimated that between 0.5 and 1 percent of the population lives with this disease. Although the most obvious signs appear on the skin, flares and their unpredictable nature can affect rest, emotional well-being, social life, work or academic performance, and the autonomy of those affected. Despite the advances achieved in understanding and treatment, there are still gaps in diagnosis, coordination between care levels, access to specialized care, the information available, and long-term follow-up.

As a result of this analysis, five shared commitments have been defined: to recognize the overall impact of the disease; to ensure that patients are informed and participate in decision-making; to achieve complete control in the shortest time possible; to ensure a swift, coordinated, and equitable care pathway; and to integrate the patient’s experience into the design and improvement of healthcare.

Clear care pathways and better coordination

To meet these needs, the authors of the consensus consider it a priority to implement well-defined care pathways, strengthen coordination between Primary Care and the hospital setting, facilitate continuity of care, and direct follow-up toward complete control of chronic urticaria, understood as the absence of signs and symptoms while the patient is undergoing treatment.

"This consensus highlights the need to strengthen coordination between professionals and care levels to help each patient move toward complete control of the disease," the allergy specialist responsible for the monographic consultation on chronic urticaria at the Complexo Hospitalario Universitario A Coruña (CHUAC), Dr. Beatriz Veleiro, has stated in this regard, advocating for "more agile, connected and homogeneous care models".

Along the same lines, the dermatologist specialist in chronic urticaria at the Hospital del Mar Research Institute and the Universitat Pompeu Fabra de Barcleona, Dr. Ana María Giménez Arnau, has stressed that "it is much more than a skin disease," since "its unpredictability can generate constant physical and emotional strain that often goes unnoticed." "Therefore, its approach must incorporate the emotional and social dimensions, in addition to controlling signs and symptoms," she emphasized.

These two specialists are part of the advisory committee, along with the representative of the Foro Español de Pacientes (FEP), Santiago Alfonso; the Primary Care physician at the Centro de Salud Almendrales in Madrid, Dr. David Palacios; the head of the Pharmacy Service and attached to the Medical Directorate of the Hospital General de Granollers (Barcelona), Nuria Rudi; and the member of the Asociación Grupo de Apoyo a Pacientes de Urticaria Crónica (AGAPUC), Marina Dávila.

In the opinion of the latter, "when urticaria is not under control, it is not only about itching or wheals," since "it can mean not sleeping, not having a social life, or avoiding certain situations for fear of suffering a flare-up." "That this consensus incorporates this reality and the experience of patients represents an important step," she concluded.